Nitric oxide and oxidative stress modulation Preclinical work suggests context-dependent effects on nitric oxide signaling and free radical activity
Legal battle involving peptide restrictions The backstory: A legal challenge spearheaded by EVEXIAS Life Sciences is actively fighting the FDA's placement of 17 peptides on its restrictive "Category 2" list, which effectively bans compounding pharmacies from making them under the claim that they are unsafe
Manufactured under stringent quality control protocols, these capsules provide a consistent and stable formulation widely used for experimental research purposes
no completed Phase 1-3 human trials
16 1226112287, Kiyama R and Wada-Kiyama Y 2015 Estrogenic endocrine disruptors: Molecular mechanisms of action
Berk M, Berk L, Davey CG, Moylan S, Giorlando F, Singh AB, et al